SALUS Ljubljana d. d Past Earnings Performance
Past criteria checks 5/6
SALUS Ljubljana d. d has been growing earnings at an average annual rate of 10%, while the Healthcare industry saw earnings growing at 13% annually. Revenues have been growing at an average rate of 13.1% per year. SALUS Ljubljana d. d's return on equity is 16.1%, and it has net margins of 2%.
Key information
10.0%
Earnings growth rate
9.8%
EPS growth rate
Healthcare Industry Growth | 13.4% |
Revenue growth rate | 13.1% |
Return on equity | 16.1% |
Net Margin | 2.0% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
SALUS Ljubljana d. d (LJSE:SALR) Is Due To Pay A Dividend Of €35.00
Mar 14SALUS, Ljubljana, d. d.'s (LJSE:SALR) 28% Price Boost Is Out Of Tune With Earnings
Feb 06SALUS Ljubljana d. d (LJSE:SALR) Will Pay A Dividend Of €35.00
Dec 30SALUS Ljubljana d. d (LJSE:SALR) Has Announced A Dividend Of €35.00
Apr 05We Think You Should Be Aware Of Some Concerning Factors In SALUS Ljubljana d. d's (LJSE:SALR) Earnings
Mar 22SALUS Ljubljana d. d (LJSE:SALR) Has Announced A Dividend Of €35.00
Mar 12SALUS Ljubljana d. d (LJSE:SALR) Has A Pretty Healthy Balance Sheet
Sep 21We Like These Underlying Return On Capital Trends At SALUS Ljubljana d. d (LJSE:SALR)
Jun 02With EPS Growth And More, SALUS Ljubljana d. d (LJSE:SALR) Is Interesting
May 13These 4 Measures Indicate That SALUS Ljubljana d. d (LJSE:SALR) Is Using Debt Reasonably Well
Apr 22Shareholders Of SALUS Ljubljana d. d (LJSE:SALR) Must Be Happy With Their 274% Total Return
Mar 17Are Strong Financial Prospects The Force That Is Driving The Momentum In SALUS, Ljubljana, d. d.'s LJSE:SALR) Stock?
Feb 12The Price Is Right For SALUS, Ljubljana, d. d. (LJSE:SALR)
Jan 26There's A Lot To Like About SALUS Ljubljana d. d's (LJSE:SALR) Upcoming €25.00 Dividend
Jan 07SALUS Ljubljana d. d (LJSE:SALR) Seems To Use Debt Rather Sparingly
Dec 24How Does SALUS, Ljubljana, d. d. (LJSE:SALR) Fare As A Dividend Stock?
Dec 02Revenue & Expenses Breakdown
How SALUS Ljubljana d. d makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 642 | 13 | 53 | 0 |
30 Jun 24 | 632 | 12 | 52 | 0 |
31 Mar 24 | 623 | 11 | 50 | 0 |
31 Dec 23 | 599 | 10 | 47 | 0 |
30 Sep 23 | 564 | 11 | 43 | 0 |
30 Jun 23 | 537 | 12 | 55 | 0 |
31 Mar 23 | 511 | 12 | 40 | 0 |
31 Dec 22 | 496 | 13 | 40 | 0 |
30 Sep 22 | 496 | 12 | 41 | 0 |
30 Jun 22 | 488 | 12 | 26 | 0 |
31 Mar 22 | 477 | 12 | 39 | 0 |
31 Dec 21 | 458 | 13 | 38 | 0 |
30 Sep 21 | 438 | 14 | 36 | 0 |
30 Jun 21 | 426 | 13 | 35 | 0 |
31 Mar 21 | 407 | 13 | 34 | 0 |
31 Dec 20 | 401 | 10 | 33 | 0 |
30 Sep 20 | 385 | 8 | 32 | 0 |
30 Jun 20 | 368 | 7 | 31 | 0 |
31 Mar 20 | 364 | 6 | 30 | 0 |
31 Dec 19 | 348 | 6 | 29 | 0 |
30 Sep 19 | 320 | 6 | 24 | 0 |
30 Jun 19 | 298 | 5 | 20 | 0 |
31 Mar 19 | 276 | 5 | 16 | 0 |
31 Dec 18 | 253 | 4 | 13 | 0 |
30 Sep 18 | 249 | 3 | 12 | 0 |
30 Jun 18 | 247 | 4 | 12 | 0 |
31 Mar 18 | 239 | 4 | 12 | 0 |
31 Dec 17 | 233 | 4 | 12 | 0 |
30 Sep 17 | 228 | 4 | 11 | 0 |
30 Jun 17 | 226 | 4 | 11 | 0 |
31 Mar 17 | 223 | 3 | 11 | 0 |
31 Dec 16 | 220 | 3 | 11 | 0 |
30 Sep 16 | 213 | 3 | 11 | 0 |
30 Jun 16 | 207 | 3 | 10 | 0 |
31 Mar 16 | 203 | 3 | 10 | 0 |
31 Dec 15 | 200 | 3 | 11 | 0 |
30 Sep 15 | 199 | 4 | 12 | 0 |
30 Jun 15 | 195 | 4 | 13 | 0 |
31 Mar 15 | 191 | 4 | 13 | 0 |
31 Dec 14 | 189 | 4 | 13 | 0 |
30 Sep 14 | 192 | 3 | 12 | 0 |
30 Jun 14 | 194 | 2 | 12 | 0 |
31 Mar 14 | 193 | 2 | 12 | 0 |
Quality Earnings: SALR has high quality earnings.
Growing Profit Margin: SALR's current net profit margins (2%) are higher than last year (2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SALR's earnings have grown by 10% per year over the past 5 years.
Accelerating Growth: SALR's earnings growth over the past year (15.7%) exceeds its 5-year average (10% per year).
Earnings vs Industry: SALR earnings growth over the past year (15.7%) exceeded the Healthcare industry 15.5%.
Return on Equity
High ROE: SALR's Return on Equity (16.1%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/21 12:26 |
End of Day Share Price | 2025/01/17 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
SALUS, Ljubljana, d. d. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|